This HTML5 document contains 34 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/drugbank/drug/DB08720/identifier/pdb/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://linked.opendata.cz/resource/drugbank/drug/DB08720/identifier/drugbank/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n7http://linked.opendata.cz/resource/drugbank/drug/DB08720/identifier/chemspider/

Statements

Subject Item
n2:DB08720
rdf:type
n3:Drug
n3:description
5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole is a solid. This compound belongs to the phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. This drug is known to target genome polyprotein.
n3:group
experimental
owl:sameAs
n10:DB08720 n11:DB08720
dcterms:title
5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole
adms:identifier
n6:W35 n7:1720 n8:DB08720
n3:IUPAC-Name
n4:271B4D46-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4D4C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4D4B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4D48-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4D49-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4D4A-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4D44-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4D42-363D-11E5-9242-09173F13E4C5 n4:271B4D45-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4D43-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4D52-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4D53-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4D4D-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4D4E-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4D50-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4D4F-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4D51-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4D57-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4D59-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4D5A-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4D56-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4D55-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4D58-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4D47-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4D54-363D-11E5-9242-09173F13E4C5